Revolutions Medical Corporation New Corporate Headquarters

MOUNT PLEASANT, S.C.--(BUSINESS WIRE)--Since the Revolutions Medical Corporation's (OTCBB: RMCP - News)recent FDA 510K Clearance for our proprietary RevVac safety syringe, the company has decided to move to a new Corporate Sales Headquarters in Charleston, S.C. The headquarters will be complete June 2009 and will be close to the port of Charleston and the shipping terminals. Charleston S.C. is home to the seventh largest container port in the U.S. (second largest East Coast) and will be our main shipping hub for our safety syringe. "This is an ideal location for Revolutions Medical to operate its global sales efforts for all of its new proprietary products," states Ron Wheet CEO.

For more information about Revolution Medical Corporation please go to www.revolutionsmedical.com or call Investor Relations 843-408-6265.

Safe Harbor

Forward-looking statements made in this release are made pursuant to the "safe-harbor" provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made by Revolutions Medical Corporation are not a guarantee of future performance. This news release includes forward- looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty.

Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Revolutions Medical Corporation, and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition.

Contact:

Revolution Medical Corporation Investor Relations, 843-408-6265

MORE ON THIS TOPIC